#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinitis pigmentosa KBG syndrome Peripheral T-cell lymphoma unspecified Angiosarcoma recurrent Human papilloma virus immunisation Germ cell cancer Epilepsy with myoclonic-atonic seizures Haemophilia B without inhibitors Nephroblastoma Chronic myeloid leukaemia Mixed-type liposarcoma Peritoneal neoplasm Marginal zone lymphoma Progressive familial intrahepatic cholestasis Growth hormone deficiency More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II – Life with Disease Glycogen storage disease type V – Treatment Breast angiosarcoma – Life with Disease Piriformis syndrome Mantle cell lymphoma stage III Breast angiosarcoma metastatic Epidermolysis bullosa Advanced systemic mastocytosis – Diagnostics Noonan syndrome – Trials in Disease Proteus syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ixazomib Citrate VERT-002 Hydroxi-Methionine Calcium Protein C Brigatinib Blu-263 Phosphate Bemarituzumab Betamethasone Acetate MRNA-1345 Procarbazine Brepocitinib Tosilate Chlortalidone Kd050 SODIUM BENZOATE AAV9-CTNT-COBAG3 Alternaria Alternata (402) Dapirolizumab Pegol Phenprocoumon Tianeptine Donidalorsen More therapies…

    Learn about Your Condition

    Mucopolysaccharidosis I Onychomycosis Renal impairment Diabetic foot Psychotic disorder Lymphocytic leukaemia Cartilage injury Critical illness Lichen planus Cholestatic pruritus Staphylococcal infection SAPHO syndrome Thyroid cancer metastatic Post procedural oedema Acute kidney injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Ivosidenib, Durvalumab, and Gemcitabine/Cisplatin for Patients with Advanced Cholangiocarcinoma with IDH1 Mutation

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Cisplatin
    • Durvalumab
    • Gemcitabine
    France Germany Spain

  • Study on Airway Changes in Patients with Residual Neuromuscular Blockade Using Sugammadex and Rocuronium Bromide

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Rocuronium Bromide
    • Sugammadex
    Hungary

  • Study on the Effects of CD34+ Cells for Patients with Acute Ischemic Stroke

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • AUTOLOGOUS CD34+ ENRICHED CELL FRACTION THAT CONTAINS CD34+ CELLS TRANSDUCED WITH RETROVIRAL VECTOR THAT ENCODES FOR THE HUMAN ADA CDNA SEQUENCE
    Portugal

  • Study on the Effects of TOUR006 for Adults with Thyroid Eye Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • HUMAN IGG2 MONOCLONAL ANTIBODY AGAINST IL-6
    France Italy Latvia Poland Slovakia Spain

  • Study on Prostate Cancer: Comparing Stereotactic Body Radiation Therapy Alone or with Triptorelin and Bicalutamide for Patients with Acinar Cell Prostatic Carcinoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Bicalutamide
    • Triptorelin
    Italy

  • Study on the Effectiveness of Biotin and Biotin Sodium for Children with Metabolic Disorders

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Biotinidase deficiency
    Investigated Drugs:
    • Biotin
    Spain
Previous Page
1 … 818 819 820 821 822 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!